- Home
- ACNB vs SIGA Comparison
ACNB vs SIGA Comparison
Compare ACNB & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACNB | SIGA |
|---|---|---|
| Founded | 1857 | 1995 |
| Country | United States | United States |
| Employees | N/A | 45 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.6M | 462.6M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | ACNB | SIGA |
|---|---|---|
| Price | $52.42 | $6.30 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $49.50 | N/A |
| AVG Volume (30 Days) | 24.4K | ★ 374.9K |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | 2.94% | ★ 9.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.34 | 1.03 |
| Revenue | $136,676,000.00 | ★ $172,249,641.00 |
| Revenue This Year | $41.47 | N/A |
| Revenue Next Year | $3.31 | $132.36 |
| P/E Ratio | $15.46 | ★ $6.27 |
| Revenue Growth | ★ 28.45 | N/A |
| 52 Week Low | $35.70 | $4.95 |
| 52 Week High | $52.26 | $9.62 |
Technical Indicators
Market Signals| Indicator | ACNB | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 73.71 | 44.29 |
| Support Level | $48.50 | $6.13 |
| Resistance Level | $49.85 | $6.54 |
| Average True Range (ATR) | 1.03 | 0.20 |
| MACD | 0.27 | 0.11 |
| Stochastic Oscillator | 89.05 | 64.75 |
Price Performance
Historical ComparisonAbout ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.